Cullinan Oncology, Inc. to Participate in the H.C. Wainwright Global Life Sciences Conference

Rhea-AI Summary

Cullinan Oncology (Nasdaq: CGEM) has announced that its CEO, Owen Hughes, will present at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, at 7:00 AM EST. The presentation will be available on-demand for registered attendees starting at that time. Cullinan specializes in developing a diverse pipeline of targeted oncology and immuno-oncology therapies, focusing on candidates with novel technology and advanced development stages.

CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies, today announced that the company’s Chief Executive Officer, Owen Hughes, will present at the upcoming H.C. Wainwright Global Life Sciences Conference.

Event: H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9th
Time: 7:00am EST
Location: Virtual

The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7am EST on Tuesday, March 9^th, 2021, for registered attendees only.

About Cullinan Oncology

Cullinan Oncology is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.

Contacts:

Investor Relations
investors@cullinanoncology.com

Jeff Trigilio
+1 716.725.5019
jtrigilio@cullinanoncology.com

FAQ

What is the date and time of Cullinan Oncology's presentation at the conference?

Cullinan Oncology's CEO will present at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, at 7:00 AM EST.

Who is presenting for Cullinan Oncology at the H.C. Wainwright Conference?

Owen Hughes, the CEO of Cullinan Oncology, will present at the conference.

Where can I watch Cullinan Oncology's presentation?

The presentation will be available on-demand through the H.C. Wainwright conference portal for registered attendees.

What type of therapies does Cullinan Oncology focus on?

Cullinan Oncology focuses on developing targeted oncology and immuno-oncology therapies.

What is the stock symbol for Cullinan Oncology?

The stock symbol for Cullinan Oncology is CGEM.